0000899243-21-021198.txt : 20210528 0000899243-21-021198.hdr.sgml : 20210528 20210528192948 ACCESSION NUMBER: 0000899243-21-021198 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210514 FILED AS OF DATE: 20210528 DATE AS OF CHANGE: 20210528 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Parkinson Paul CENTRAL INDEX KEY: 0001826133 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-26642 FILM NUMBER: 21982353 MAIL ADDRESS: STREET 1: 320 WAKARA WAY CITY: SALT LAKE CITY STATE: UT ZIP: 84108 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MYRIAD GENETICS INC CENTRAL INDEX KEY: 0000899923 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 870494517 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 320 WAKARA WAY CITY: SALT LAKE CITY STATE: UT ZIP: 84108 BUSINESS PHONE: 801-584-3600 MAIL ADDRESS: STREET 1: 320 WAKARA WAY CITY: SALT LAKE CITY STATE: UT ZIP: 84108 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-05-14 1 0000899923 MYRIAD GENETICS INC MYGN 0001826133 Parkinson Paul 320 WAKARA WAY SALT LAKE CITY UT 84108 0 1 0 0 Fmr EVP Strategy & Innovation Common Stock 87407 D This "Exit" Form 4 is voluntarily filed to report solely that the Reporting Person is no longer serving as the Company's EVP Strategy and Innovation, effective as of May 14, 2021, and therefore is no longer subject to Section 16 reporting. By: Nathan A. Smith For: Paul Parkinson 2021-05-28